Combined analysis of allograft inflammatory factor-1, interleukin-18, and Toll-like receptor expression and association with allograft rejection and coronary vasculopathy

American Surgeon

Volumn 76, Issue 8, 2010, Pages 872-878

  Barker, Andrea K ^a   McDaniel, D Olga ^a   Zhou, Xinchun ^a   He, Zelda ^a   Aru, Giorgio ^a   Thomas, Tammy ^a   Moore, Charles K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; BETA ACTIN; BIOLOGICAL MARKER; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; AIF1 PROTEIN, HUMAN; DNA BINDING PROTEIN; TOLL LIKE RECEPTOR;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; GRAFT RECIPIENT; HEART LUNG TRANSPLANTATION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CHEMISTRY; CORONARY ARTERY DISEASE; ENDOCARDIUM; GRAFT REJECTION; POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKERS; CORONARY DISEASE; DNA-BINDING PROTEINS; ENDOCARDIUM; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-18; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTORS;

EID: 77956216951     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Taylor DO, Stehlik J, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: twentysixth official adult heart transplant report-2009. J Heart Lung Transplant 2009;28:1007-22.
2. Kass M, Haddad H. Cardiac allograft vasculopathy: pathology, prevention and treatment. Curr Opin Cardiol 2006;21:132-7. (Pubitemid 44378293)
3. Taylor DO, Edwards LB, Boucek MM, et al. Registry of International Society for Heart and Lung Transplantation: twenty-second Official Adult Heart Transplant Report - 2005. J Heart Lung Transplant 2005;24:945-55.
4. Land WG. Innate immunity-mediated allograft rejection and strategies to prevent it. Transplant Proc 2007;39:667-72.
5. Kaczorowski DJ, Mollen KP, Edmonds R, Billiar TR. Early events in the recognition of danger signals after tissue injury. J Leukoc Biol 2008;83:546-52. (Pubitemid 351966863)
6. Dudler J, Simoni E, Fleury E, et al. Gene transfer of interleukin-IL-18 binding protein attenuates cardiac allograft rejection. Transpl Int 2007;20:460-6. (Pubitemid 46535983)
7. Autieri MV, Kelemen S, Thomas BA, et al. Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy. Circulation 2002;106:2218-23. (Pubitemid 35222216)
8. Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007;4:444-54. (Pubitemid 47180328)
9. Yang ZF, Ho DW, Lau CK, et al. Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages. Int Immunol 2005;17:1391-7.
10. Kelemen SE, Autieri MV. Expression of allograft inflammatory factor-1 in T lymphocytes: a role in T-lymphocyte activation and proliferative arteriopathies. Am J Pathol 2005;167:619-26.
11. Autieri MV, Carbone C, Mu A. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury. Arterioscler Thromb Vasc Biol 2000;20:1737-44. (Pubitemid 30470588)
12. Deininger MH, Seid K, Engel S, et al. Allograft inflammatory factor-1 defines a distinct subset of infiltrating macrophages/microglial cells in rat and human gliomas. Acta Neuropathol 2000;100:673-80.
13. Iris FAJ, Bouguelert L, Prieur S, et al. Dense Alu clustering and a potential new member of the NF-kB family within a 90 kilobase HLA class III segment. Nat Genet 1993;3:137-45. (Pubitemid 23079796)
14. Mishima T, Iwabuchi K, Fujii S, et al. Allograft inflammatory factor-1 augments macrophage phagocytotic activity and accelerates the progression of atherosclerosis in ApoE-/- mice. Int J Mol Med 2008;21:181-7. (Pubitemid 351222851)
15. Autieri MV, Kelemen SE, Wendt KW. AIF-1 is an actin-polymerizing and Rac1-activating protein that promotes vascular smooth muscle cell migration. Circ Res 2003;92:1107-14.
16. Kuschel R, Deininger MH, Meyermann R, et al. Allograft inflammatory factor-1 is expressed by macrophages in injured skeletal muscle and abrogates proliferation and differentiation of satellite cells. J Neuropathol Exp Neurol 2000;59:323-32. (Pubitemid 30183700)
17. Liu G, Ma H, Jiang L, Zhou Y. Allograft inflammatory factor-1 and its immunoregulation. Autoimmunity 2007;40:95-102.
18. McDaniel DO, Yamout S, Aru G, et al. Cytokine genes associated with CV following transplantation. In: Int Proc Immunol 2004, Medimond, Bologna Italy. p. 493-9.
19. Beutler B. Inferences, questions and possibilities in Toll-like receptor signaling. Nature 2004;430:257-63. (Pubitemid 38902439)
20. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14.
21. Leemaus JC, Butter LM, Pulsken WP, et al. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One 2009;4:e5704.
22. Methe H, Zimmer E, Grimm C, et al. Evidence for a role of Toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004;78:1324. (Pubitemid 39507972)
23. Kim BS, Lim SW, Li C, et al. Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 2005;79:1370. (Pubitemid 40740256)
24. Stewart S, Winter GL, Fishbein MC, et al. Revision of 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005;24:1710-20.
25. McDaniel DO, Roten DP, Yamout SZ, et al. Cytokine gene polymorphism might affect the outcome of clinical rejection in cardiac transplantation. J Applied Res 2004;4:68-80. (Pubitemid 39406821)
26. McDaniel DO, Piazza LK, Zhou X, et al. Allograft inflammatory factor-1 and IL-18 genotypes and expression levels in association with rejection and allograft vasculopathy after transplantation. Hum Immunol 2010; in press.
27. Autieri MV. cDNA cloning of human allograft inflammatory factor-1: tissue distribution, cytokine induction and mRNA expression in injured rat carotid arteries. Biochem Biophys Res Commun 1996;228:29-37.
28. Autieri MV, Carbone CM. Overexpression of allograft inflammatory factor-1 promotes proliferation of vascular smooth muscle cells by cell cycle deregulation. Arterioscler Thromb Vasc Biol 2001;21:1421-6.
29. Tian Y, Jian S, Kelemen SE, Autieri MV. AIF-1 expression regulates endothelial cell activation, signal transduction, and vasculogenesis. Am J Physiol Cell Physiol 2009;296:c256-c266.
30. Thompson SR, Humphries SE. Interleukin-18 genetics and inflammatory disease susceptibility. Genes Immunol 2007;8:91-9.
31. Hernesniemi JA, Karhunen PJ, Rontu R. Interleukin-18 promoter polymorphism associated with the occurrence of sudden cardiac death among Caucasian males: the Helsinki Sudden Death Study. Atherosclerosis 2008;196:643-9. (Pubitemid 351146659)
32. Rifkin IR, Leadbetter EA, Busconi L, et al. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 2005;204:27-42. (Pubitemid 40460491)
33. de Kleijn D, Pasterkamp G. Toll-like receptors in cardiovascular diseases. Cardiovasc Res 2003;60:58-67.
34. Tsujimoto H, Ono S, Efron PA, et al. Role of Toll-like receptors in the development of sepsis. Shock 2008;29:315-21. (Pubitemid 351271701)
35. Methe H, Zimmer E, Grimm C, et al. Evidence for a role of Toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004;78:1324-31. (Pubitemid 39507972)
36. Goldstein DR. Toll like receptors and acute allograft rejection. Transpl Immunol 2006;17:11-5.
37. de Groot K, Kuklik K, Bröcker V, et al. Toll-like receptor 2 and renal allograft function. Am J Nephrol 2008;28:583-8. (Pubitemid 351832445)
38. Li M, Carpio DF, Zheng Y, et al. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001;166:7128-35. (Pubitemid 32525583)
39. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006;6:2282-91. (Pubitemid 44359413)
40. LaRosa DF, Rahman AH, Turka LA. The innate immune system in allograft rejection and tolerance. J Immunol 2007;178:7503-9.